Advisor Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $2.87M | Buy |
19,070
+1,541
| +9% | +$232K | 0.02% | 650 |
|
|
2019
Q3 | $2.49M | Sell |
17,529
-504
| -3% | -$71.5K | 0.02% | 669 |
|
|
2019
Q2 | $2.26M | Buy |
18,033
+1,299
| +8% | +$163K | 0.02% | 708 |
|
|
2019
Q1 | $1.84M | Buy |
16,734
+4,199
| +33% | +$463K | 0.02% | 753 |
|
|
2018
Q4 | $1.23M | Buy |
12,535
+1,916
| +18% | +$188K | 0.01% | 844 |
|
|
2018
Q3 | $1.31M | Buy |
10,619
+3,511
| +49% | +$433K | 0.01% | 827 |
|
|
2018
Q2 | $705K | Buy |
7,108
+752
| +12% | +$74.6K | 0.01% | 1085 |
|
|
2018
Q1 | $561K | Sell |
6,356
-2,603
| -29% | -$230K | 0.01% | 1237 |
|
|
2017
Q4 | $884K | Buy |
8,959
+981
| +12% | +$96.8K | 0.01% | 974 |
|
|
2017
Q3 | $767K | Sell |
7,978
-18
| -0.2% | -$1.73K | 0.01% | 960 |
|
|
2017
Q2 | $756K | Buy |
7,996
+1,724
| +27% | +$163K | 0.01% | 899 |
|
|
2017
Q1 | $513K | Buy |
6,272
+228
| +4% | +$18.6K | 0.01% | 1060 |
|
|
2016
Q4 | $513K | Buy |
6,044
+1,404
| +30% | +$119K | 0.01% | 1007 |
|
|
2016
Q3 | $346K | Buy |
4,640
+915
| +25% | +$68.2K | 0.01% | 1188 |
|
|
2016
Q2 | $281K | Buy |
+3,725
| New | +$281K | 0.01% | 1225 |
|